Provided by Tiger Trade Technology Pte. Ltd.

LISATA THERAPEUTICS INC

1.55
+0.430038.39%
Post-market: 1.640.0900+5.81%19:59 EDT
Volume:7.12M
Turnover:10.96M
Market Cap:13.97M
PE:-0.94
High:1.79
Open:1.11
Low:1.10
Close:1.12
52wk High:5.07
52wk Low:0.9875
Shares:9.01M
Float Shares:7.11M
Volume Ratio:103.53
T/O Rate:100.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6418
EPS(LYR):-1.9100
ROE:-101.66%
ROA:-56.74%
PB:1.69
PE(LYR):-0.81

Loading ...

U.S. Stocks on the MOVE-Expeditors International, Waters, Wayfair

Reuters
·
Aug 05

Lisata Therapeutics provides update following termination of Kuva Labs merger

TIPRANKS
·
Aug 04

Lisata Therapeutics Sues Kuva Labs over Breached Merger Agreement, Seeks $2 Million Fee

Reuters
·
Aug 04

Lisata Therapeutics - Eliminates Executive Vice President of R&D and Chief Medical Officer Position

THOMSON REUTERS
·
Aug 04

Lisata Therapeutics - Implements Reduction in Force of About 72% of Full-Time Employees

THOMSON REUTERS
·
Aug 04

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

THOMSON REUTERS
·
Aug 04

Lisata Therapeutics - Seeks $2 Mln Termination Fee from Kuva Under Merger Agreement

THOMSON REUTERS
·
Aug 04

Lisata Therapeutics - Board Continues to Evaluate Strategic Alternatives to Enhance Stockholder Value

THOMSON REUTERS
·
Aug 04

Lisata Therapeutics - Files Suit Against Kuva Labs Seeking Damages for Stockholders

THOMSON REUTERS
·
Aug 04

Lisata Therapeutics Cuts Workforce About 72% in Reorganization

Reuters
·
Aug 04

Lisata Therapeutics - Estimates $1.20 Mln of Costs Related to Workforce Reduction Through Qtr Ending Sept 30, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 04

Lisata Therapeutics - on Aug 3, Approved Reduction in Workforce by About 72% Effective Immediately - SEC Filing

THOMSON REUTERS
·
Aug 04

Lisata Therapeutics - Terminates Kristen K. Buck as Evp of R&D and Chief Medical Officer Effective Aug 3, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 04

Lisata Therapeutics - on July 31, Commenced Legal Action Against Kuva Labs and Kuva Acquisition Corp. for Breach of Merger Agreement - SEC Filing

THOMSON REUTERS
·
Aug 04

Lisata Therapeutics terminates merger with Kuva Labs

TIPRANKS
·
Jul 27

Lisata Therapeutics Shares Fall After Terminating Kuva Labs Deal

MT Newswires Live
·
Jul 25

Lisata Therapeutics - Board to Assess Strategic Options Including Reverse Merger or Asset Sales - SEC Filing

THOMSON REUTERS
·
Jul 25

Lisata Therapeutics - Terminates Merger Agreement with Kuva Labs on July 24, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 25

U.S. Stocks on the Move-duke Robotics, Tesla, Hasbro

Reuters
·
Jul 22

Lisata Tumbles as Buyer Kuva Fails to Fund Takeover on Time

Reuters
·
Jul 21